Product
HDARAC
1 clinical trial
1 indication
Indication
Acute Lymphocytic LeukemiaClinical trial
Multicenter Study To Optimize Treatment in Elderly Patients (> 55 Years, No Upper Age Limit) With Acute Lymphoblastic Leukemia (GMALL Elderly 1/2003)(Amend 2)Status: Completed, Estimated PCD: 2011-06-01